Injectable Chitosan Hydrogels with Enhanced Mechanical Properties for Nucleus Pulposus Regeneration
Publication: Tissue Engineering Part A
Volume 25, Issue Number 5-6
Abstract
Intervertebral disc (IVD) degeneration has been implicated as a major component of spine pathology. As the IVD degenerates, the tissue becomes dehydrated, fibrotic, fissured, acellular, and calcified. These changes can lead to disc bulging, herniation, Schmorl's nodes, inflammation, and hyperinnervation. Injectable hydrogels have received much attention in recent years as scaffold for seeding cells to replenish disc cellularity and restore disc properties and function. However, they generally present poor mechanical properties. In this study, we investigate several novel thermosensitive chitosan hydrogels for their ability to mimic the mechanical properties of the nucleus pulposus (NP) tissue, while being injectable, able to entrap and maintain viability of NP cells, and retain matrix proteins. These new hydrogels were prepared by mixing chitosan (CH) with various combinations of three gelling agents: sodium hydrogen carbonate (SHC) and/or beta-glycerophosphate (BGP) and/or phosphate buffer (PB). The kinetics of gelation was studied at room and body temperature by rheology. Mechanical properties of the hydrogels were characterized under compression and torsion, and compared with human NP tissue. NP cells were seeded in the hydrogel when still liquid at room temperature, before its gelation at 37°C. Hydrogel cytocompatibility and functionality were assessed by measuring cell viability, metabolism, and proteoglycan synthesis. Although all the proposed hydrogels exhibited enhanced strength compared to CH-BGP thermosensitive hydrogels, and suitable cytocompatibility and rheological properties, one formulation (containing 2% chitosan, 7.5 mM of SHC, and 0.1 M of BGP) showed mechanical properties similar to human NP tissue, and stimulated better the synthesis and retention of proteoglycans from NP cells. Thus, this novel thermosensitive CH hydrogel shows promise for IVD regeneration.
Impact Statement
A thermosensitive chitosan-based hydrogel was developed, which mimics the mechanical properties of the human nucleus pulposus (NP) tissue and provides a suitable environment for seeded NP cells to live and produce glycosaminoglycans. This scaffold is injectable through 25G needle and rapidly gels in vivo at body temperature. It has the potential to restore mechanical properties and stimulate biological repair of the degenerated intervertebral disc (IVD). It could therefore be used for the minimally invasive treatment of degenerated IVD, which affects more than one person out of five in the world.
Get full access to this article
View all available purchase options and get full access to this article.
References
1. Vergroesen P.A., van der Veen A.J., Emanuel K.S., van Dieën J.H., and Smit T.H. The poro-elastic behaviour of the intervertebral disc: a new perspective on diurnal fluid flow. J Biomech 49, 857, 2016.
2. Rannou F., Mayoux-Benhamou M.-A., Poiraudeau S., and Revel M. Disqueintervertébral et structures voisines de la colonne lombaire: anatomie, biologie, physiologie et biomécanique. EMC Rhumatol Orthop 1, 487, 2004.
3. Freemont A.J. The cellular pathobiology of the degenerate intervertebral disc and discogenic back pain. Rheumatology 48, 5, 2009.
4. Antoniou J., Epure L.M., Michalek A.J., Grant M.P., Iatridis J.C., and Mwale F. Analysis of quantitative magnetic resonance imaging and biomechanical parameters on human discs with different grades of degeneration. J Magn Reson Imaging 38, 1402, 2013.
5. Roughley P.J. Biology of intervertebral disc aging and degeneration: involvement of the extracellular matrix. Spine (Phila Pa 1976) 29, 2691, 2004.
6. Costi J.J., Freeman B.J., and Elliott D.M. Intervertebral disc properties: challenges for biodevices. Expert Rev Med Devices 8, 357, 2011.
7. Chan S.C.W., and Gantenbein-Ritter B. Intervertebral disc regeneration or repair with biomaterials and stem cell therapy—feasible or fiction? Swiss Med Wkly 142, w13598, 2012.
8. Abramovitz J.N., and Neff S.R. Lumbar disc surgery: results of the Prospective Lumbar Discectomy Study of the Joint Section on Disorders of the Spine and Peripheral Nerves of the American Association of Neurological Surgeons and the Congress of Neurological Surgeons. Neurosurgery 29, 301, 1991;. discussion 307–308.
9. Snider R.K., Krumwiede N.K., Snider L.J., Jurist J.M., Lew R.A., and Katz J.N. Factors affecting lumbar spinal fusion. J Spinal Disord 12, 107, 1999.
10. Blanquer S.B., Grijpma D.W., and Poot A.A. Delivery systems for the treatment of degenerated intervertebral discs. Adv Drug Deliv Rev 84, 172, 2015.
11. Grant M., Epure L.M., Salem O., et al. Development of a large animal long-term intervertebral disc organ culture model that includes the bony vertebrae for ex vivo studies. Tissue Eng Part C Methods 22, 636, 2016.
12. Grant M.P., Epure L.M., Bokhari R., Roughley P., Antoniou J., and Mwale F. Human cartilaginous endplate degeneration is induced by calcium and the extracellular calcium-sensing receptor in the intervertebral disc. Eur Cells Mater 32, 137, 2016.
13. Mizuno H. Tissue-engineered composites of anulus fibrosus and nucleus pulposus for intervertebral disc replacement. Spine (Phila Pa 1976), 29, 1290, 2004; discussion 1297–1298.
14. Rong Y., Sugumaran G., Silbert J.E., and Spector M. Proteoglycans synthesized by canine intervertebral disc cells grown in a type I collagen-glycosaminoglycan matrix. Tissue Eng 8, 1037, 2002.
15. Alini M., Li, W., Markovic P., Aebi M., Spiro R.C., and Roughley P.J. The potential and limitations of a cell-seeded collagen/hyaluronan scaffold to engineer an intervertebral disc-like matrix. Spine (Phila Pa 1976) 28, 446, 2003; discussion 453.
16. Gruber H.E., Leslie K., Ingram J., Norton H.J., and Hanley E.N. Cell-based tissue engineering for the intervertebral disc: in vitro studies of human disc cell gene expression and matrix production within selected cell carriers. Spine J 4, 44, 2004.
17. Chou A.I., and Nicoll S.B. Characterization of photocrosslinked alginate hydrogels for nucleus pulposus cell encapsulation. J Biomed Mater Res A 91, 187, 2009.
18. Roughley P., Hoemann C., DesRosiers E., Mwale F., Antoniou J., and Alini M. The potential of chitosan-based gels containing intervertebral disc cells for nucleus pulposus supplementation. Biomaterials 27, 388, 2006.
19. Grad S., Zhou L., Gogolewski S., and Alini M. Chondrocytes seeded onto poly (L/dl-lactide) 80%/20% porous scaffolds: a biochemical evaluation. J Biomed Mater Res A 66, 571, 2003.
20. Mwale F., Iordanova M., Demers C.N., Steffen T., Roughley P., and Antoniou J. Biological evaluation of chitosan salts cross-linked to genipin as a cell scaffold for disk tissue engineering. Tissue Eng 11, 130, 2005.
21. Di Martino A., Sittinger M., and Risbud M.V. Chitosan: a versatile biopolymer for orthopaedic tissue-engineering. Biomaterials 26, 5983, 2005.
22. Chenite A., Chaput C., Wang D., et al. Novel injectable neutral solutions of chitosan form biodegradable gels in situ. Biomaterials 21, 2155, 2000.
23. Ishikawa Y., and Wuthier R.E. Development of an in vitro mineralization model with growth plate chondrocytes that does not require β-glycerophosphate. Bone Miner 17, 152, 1992.
24. Assaad E., Maire M., and Lerouge S. Injectable thermosensitive chitosan hydrogels with controlled gelation kinetics and enhanced mechanical resistance. Carbohydr Polym 130, 87, 2015.
25. Ceccaldi C., Assaad E., Hui E., Buccionyte M., Adoungotchodo A., and Lerouge S. Optimization of injectable thermosensitive scaffolds with enhanced mechanical properties for cell therapy. Macromol Biosci 17, 1600435, 2017.
26. Winter H.H., and Chambon F. Analysis of linear viscoelasticity of a crosslinking polymer at the gel point. J Rheol 30, 367, 1986.
27. Cloyd J.M., Malhotra N.R., Weng L., Chen W., Mauck R.L., and Elliott D.M. Material properties in unconfined compression of human nucleus pulposus, injectable hyaluronic acid-based hydrogels and tissue engineering scaffolds. Eur Spine J 16, 1892, 2007.
28. Iatridis J.C., Weidenbaum M., Setton L.A., and Mow V.C. Is the nucleus pulposus a solid or a fluid? Mechanical behaviors of the nucleus pulposus of the human intervertebral disc. Spine (Phila Pa 1976) 21, 1174, 1996.
29. Gawri R., Antoniou J., Ouellet J., et al. Best paper NASS 2013: link-N can stimulate proteoglycan synthesis in the degenerated human intervertebral discs. Eur Cells Mater 26, 107, 2013.
30. Thompson J.P., Pearce R.H., Schechter M.T., Adams M.E., Tsang I.K., and Bishop P.B. Preliminary evaluation of a scheme for grading the gross morphology of the human intervertebral disc. Spine (Phila Pa 1976) 15, 411, 1990.
31. Joshi A., Fussell G., Thomas J., et al. Functional compressive mechanics of a PVA/PVP nucleus pulposus replacement. Biomaterials 27, 176, 2006.
32. van Dijk B., Potier E., and Ito K. Culturing bovine nucleus pulposus explants by balancing medium osmolarity. Tissue Eng Part C Methods 17, 1089, 2011.
33. Urban J., and Maroudas A. The chemistry of the intervertebral disc in relation to its physiological function and requirements. Clin Rheum Dis 6, 51, 1980.
34. Sakai D., and Schol J. Cell therapy for intervertebral disc repair: clinical perspective. J Orthop Transl 9, 8, 2017.
35. Huang Y.C., Leung V.Y., Lu W.W., and Luk K.D. The effects of microenvironment in mesenchymal stem cell-based regeneration of intervertebral disc. Spine J 13, 352, 2013.
36. Yoshikawa T., Ueda Y., Miyazaki K., Koizumi M., and Takakura Y. Disc regeneration therapy using marrow mesenchymal cell transplantation: a report of two case studies. Spine (Phila Pa 1976) 35, E475, 2010.
37. Orozco L., Soler R., Morera C., Alberca M., Sánchez A., and García-Sancho J. Intervertebral disc repair by autologous mesenchymal bone marrow cells: a pilot study. Transplantation 92, 822, 2011.
38. Coric D., Pettine K., Sumich A., and Boltes M.O. Prospective study of disc repair with allogeneic chondrocytes presented at the 2012 Joint Spine Section Meeting. J Neurosurg Spine 18, 85, 2013.
39. Noriega D.C., Ardura F., Hernández-Ramajo R., et al. Intervertebral disc repair by allogeneic mesenchymal bone marrow cells: a randomized controlled trial. Transplantation 101, 1945, 2017.
40. Kumar H., Ha D.H., Lee E.J., et al. Safety and tolerability of intradiscal implantation of combined autologous adipose-derived mesenchymal stem cells and hyaluronic acid in patients with chronic discogenic low back pain: 1-year follow-up of a phase I study. Stem Cell Res Ther 8, 262, 2017.
41. Tschugg A., Diepers M., Simone S., et al. A prospective randomized multicenter phase I/II clinical trial to evaluate safety and efficacy of NOVOCART disk plus autologous disk chondrocyte transplantation in the treatment of nucleotomized and degenerative lumbar disks to avoid secondary disease: safety results of Phase I—a short report. Neurosurg Rev 40, 155, 2017.
42. Bowles R.D., and Setton L.A. Biomaterials for intervertebral disc regeneration and repair. Biomaterials 129, 54, 2017.
43. Schutgens E.M., Tryfonidou M.A., Smit T.H., et al. Biomaterials for intervertebral disc regeneration: past performance and possible future strategies. Eur Cells Mater 30, 210, 2015.
44. Hudson K.D., Alimi M., Grunert P., Härtl R., and Bonassar L.J. Recent advances in biological therapies for disc degeneration: tissue engineering of the annulus fibrosus, nucleus pulposus and whole intervertebral discs. Curr Opin Biotechnol 24, 872, 2013.
45. Cheng Y.H., Yang S.H., Su W.Y., et al. Thermosensitive chitosan-gelatin-glycerol phosphate hydrogels as a cell carrier for nucleus pulposus regeneration: an in vitro study. Tissue Eng Part A 16, 695, 2010.
46. Ghorbani M., Ai J., Nourani M.R., et al. Injectable natural polymer compound for tissue engineering of intervertebral disc: in vitro study. Mater Sci Eng C 80, 502, 2017.
47. Richardson S.M., Hughes N., Hunt J.A., Freemont A.J., and Hoyland J.A. Human mesenchymal stem cell differentiation to NP-like cells in chitosan-glycerophosphate hydrogels. Biomaterials 29, 85, 2008.
48. Peroglio M., Eglin D., Benneker L.M., Alini M., and Grad S. Thermoreversible hyaluronan-based hydrogel supports in vitro and ex vivo disc-like differentiation of human mesenchymal stem cells. Spine J 13, 1627, 2013.
49. Vernengo J., Fussell G.W., Smith N.G., and Lowman A.M. Evaluation of novel injectable hydrogels for nucleus pulposus replacement. J Biomed Mater Res B Appl Biomater 84, 64, 2008.
50. Crevensten G., Walsh A.J., Ananthakrishnan D., et al. Intervertebral disc cell therapy for regeneration: mesenchymal stem cell implantation in rat intervertebral discs. Ann Biomed Eng 32, 430, 2004.
51. Gullbrand S.E., Schaer T.P., Agarwal P., et al. Translation of an injectable triple-interpenetrating-network hydrogel for intervertebral disc regeneration in a goat model. Acta Biomater 60, 201, 2017.
52. Zhu Y., Tan J., Zhu H., et al. Development of kartogenin-conjugated chitosan-hyaluronic acid hydrogel for nucleus pulposus regeneration. Biomater Sci 5, 784, 2017.
53. Smith L.J., Gorth D.J., Showalter B.L., et al. In vitro characterization of a stem-cell-seeded triple-interpenetrating- network hydrogel for functional regeneration of the nucleus pulposus. Tissue Eng Part A 20, 1841, 2014.
54. Whatley B.R., and Wen X. Intervertebral disc (IVD): structure, degeneration, repair and regeneration. Mater Sci Eng C 32, 61, 2012.
55. Lavertu M., Filion D., and Buschmann M.D. Heat-induced transfer of protons from chitosan to glycerol phosphate produces chitosan precipitation and gelation. Biomacromolecules 9, 640, 2008.
56. Liu L., Tang X., Wang Y., and Guo S. Smart gelation of chitosan solution in the presence of NaHCO3 for injectable drug delivery system. Int J Pharm 414, 6, 2011.
57. Li X., Kong X., Zhang J., et al. A novel composite hydrogel based on chitosan and inorganic phosphate for local drug delivery of camptothecin nanocolloids. J Pharm Sci 100, 232, 2011.
58. Nair L.S., Starnes T., Ko J.W., and Laurencin C.T. Development of injectable thermogelling chitosan-inorganic phosphate solutions for biomedical applications. Biomacromolecules 8, 3779, 2007.
59. Kumar D., Gerges I., Tamplenizza M., Lenardi C., Forsyth N.R., and Liu Y. Three-dimensional hypoxic culture of human mesenchymal stem cells encapsulated in a photocurable, biodegradable polymer hydrogel: a potential injectable cellular product for nucleus pulposus regeneration. Acta Biomater 10, 3463, 2014.
60. Xavier J.R., Thakur T., Desai P., et al. Bioactive nanoengineered hydrogels for bone tissue engineering: a growth-factor-free approach. ACS Nano 9, 3109, 2015.
61. Priyadarshani P., Li Y., and Yao L. Advances in biological therapy for nucleus pulposus regeneration. Osteoarthritis Cartilage 24, 206, 2016.
62. Thorpe A.A., Boyes V.L., Sammon C., and Le Maitre C.L. Thermally triggered injectable hydrogel, which induces mesenchymal stem cell differentiation to nucleus pulposus cells: potential for regeneration of the intervertebral disc. Acta Biomater 36, 99, 2016.
63. Johannessen W., Vresilovic E.J., Seguritan J.A., and Elliott D.M. Altered nucleus pulposus mechanics using chondroitinase-abc and genipin as a model of early disc degeneration. Trans Orthop Res Soc 29, 1150, 2004.
64. Monette A., Ceccaldi C., Assaad E., Lerouge S., and Lapointe R. Chitosan thermogels for local expansion and delivery of tumor-specific T lymphocytes towards enhanced cancer immunotherapies. Biomaterials 75, 237, 2016.
65. Ahmadi R., and de Bruijn J.D. Biocompatibility and gelation of chitosan-glycerol phosphate hydrogels. J Biomed Mater Res A 86, 824, 2008.
66. Ishihara H., Warensjo K., Roberts S., and Urban J.P. Proteoglycan synthesis in the intervertebral disk nucleus: the role of extracellular osmolality. Am J Physiol 272, C1499, 1997.
67. Wuertz K., Urban J.P., Klasen J., et al. Influence of extracellular osmolarity and mechanical stimulation on gene expression of intervertebral disc cells. J Orthop Res 25, 1513, 2007.
68. Neidlinger-Wilke C., Mietsch A., Rinkler C., Wilke H.J., Ignatius A., and Urban J. Interactions of environmental conditions and mechanical loads have influence on matrix turnover by nucleus pulposus cells. J Orthop Res 30, 112, 2012.
69. Spillekom S., Smolders L.A., Grinwis G.C., et al. Increased osmolarity and cell clustering preserve canine notochordal cell phenotype in culture. Tissue Eng Part C Methods 20, 652, 2014.
Information & Authors
Information
Published In
Copyright
Copyright 2019, Mary Ann Liebert, Inc., publishers.
History
Published online: 17 April 2019
Published in print: March 2019
Published ahead of print: 9 November 2018
Published ahead of production: 25 September 2018
Accepted: 26 July 2018
Received: 8 June 2018
Topics
Authors
Disclosure Statement
No competing financial interests exist.
Metrics & Citations
Metrics
Citations
Export Citation
Export citation
Select the format you want to export the citations of this publication.
View Options
Get Access
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.⚠ Society Access
If you are a member of a society that has access to this content please log in via your society website and then return to this publication.